ES CN EN
Current location:Home Product Center PCR TEST KIT Respiratory Disease
Introduction
Product Features
Specification
Q&A
2019-Novel Coronavirus Mutants Test Kit
Diagnosis of 2019-Novel Coronavirus Mutants Infection
This kit is intended for qualitative detection of ORF genes of 2019-Novel Coronavirus (2019-nCoV, SARS-COV-2) and mutants including B.1.1.7(α), B.1.351(β),P.1(γ), B.1.617.2(δ),B.1.617.1(κ),B.1.525(η) and B.1.620.
Product manual
Download Browse
Introduction
Product Features
Specification
Q&A
Introduction

The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. During the pandemic, various mutants appeared and showed different characters.

Introduction More
Product Features
Specification
Product Name
2019-Novel Coronavirus Mutants Test Kit
Package Specification
50 Tests/Box
Storage Condition

The shelf life of this kit is 9 months when stored in freezer at – (20±5) ℃.

Performance

1. The limit detection of the kit is 200 copies/mL-1.

2. Precision: The coefficient of variation of Ct values ofprecision references is not higher than 5% within-batch and not higher than 10% inter-batch.

3. Specificity: 1mg/mL-1mucin and 10% blood in the tested sample will have no influence on the detection. However, try to avoid such substances which may have potential influence on PCR reaction during sampling.



Q & A
You may be interested in: